Announces Q1 (Standalone & Consolidated) results, Limited Review Report (Standalone & Consolidated), Results Press Release, Management Discussion & Analysis for the Quarter ended June 30, 2016

• Security Code: 532296
• Company: GLENMARK

Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended June 30, 2016:

The Unaudited Standalone results for the Quarter ended June 30, 2016

The Company has posted a net profit of Rs. 5188.05 million for the quarter ended June 30, 2016 as compared to Rs. 3385.73 million for the quarter ended June 30, 2015. Total Income has increased from Rs. 12738.53 million for the quarter ended June 30, 2015 to Rs. 17387.98 million for the quarter ended June 30, 2016.

The Consolidated Results are as follows:

The Unaudited Consolidated results for the Quarter ended June 30, 2016

The Group has posted a net profit after tax, minority interest and share of profit of associates of Rs. 2267.80 million for the quarter ended June 30, 2016 as compared to Rs. 1829.45 million for the quarter ended June 30, 2015. Total Income has increased from Rs. 16531.14 million for the quarter ended June 30, 2015 to Rs. 20189.73 million for the quarter ended June 30, 2016.